Introduction
The 2-iminothiazoline scaffold is found in many bioactive heterocycles, which have a wide variety of pharmaceutical applications such as analgesic, antipyretic, antirheumatic, 1 anti-Schistosomiasis, 2 and anti-HIV activities. 3−5 Bis-thiazoline derivatives are potent antitumor, 6, 7 antihistaminic, 8 antihypertensive, 9 hypnotic, 10 and antimycobacterial and potent antibacterial agents. 11, 12 Coumarin derivatives of thiazolines display significant anticonvulsant activities against PTZ-induced seizures. 13, 14 Thiazoline analogues also inhibit the enzyme indoleamine-N -methyltransferase and are useful for the treatment of schizophrenia. 
Experimental
Melting points were recorded using a digital Gallenkamp (SANYO) model MPD.BM 3.5 apparatus and are uncorrected. 1 H NMR (300 MHz) and 13 C NMR (75 MHz) spectra were recorded using a Bruker AM-300 spectrophotometer. FTIR spectra were recorded on an FTS 3000 MX spectrophotometer. Mass spectra (EI, 70 eV) were recorded on a GC-MS instrument (Agilent Technologies) and elemental analyses were conducted using a LECO-183 CHNS analyzer. Thin layer chromatography (TLC) was conducted on 0.25-mm silica gel plates (60 F254, Merck). Visualization of chromatograms was performed with UV at 365 and 254 nm.
1-(Benzo[d]thiazol-2-yl)-3-aroyl thioureas were prepared according to a method reported earlier. 
General procedures for the synthesis of N-[3-(benzo[d]thiazol-2-yl)-4-methylthiazol-2(3H)-ylidene] substituted benzamides (2a-k)
A solution of 1-(benzo[d]thiazol-2-yl)-3-aroyl thioureas (1a-k) (3 mmol) in 20 mL of dry acetone was stirred under inert atmosphere. Triethylamine (3 mmol) was added dropwise through the rubber septum using a syringe (3 mL), and then a solution of bromine (3 mmol) in dry acetone (10 mL) was added slowly. The reaction mixture was allowed to stir for 3-4 h. After completion (monitored by TLC), the reaction mixture was filtered and the filtrate was concentrated to get crude
benzamides (2a-k), which were then recrystallized from ethanol to afford pure products. 
N-[3-(Benzo[d]thiazol-2-yl)-4-methylthiazol-2(3H)-ylidene] benzamide (2a)

N-[3-(Benzo[d]thiazol-2-yl)-4-methylthiazol-2(3H)-ylidene]-4-methylbenzamide (2c)
(
2-Bromo-N-[4-methyl-3-(6-methylbenzo[d]thiazol-2-yl)thiazol-2(3H)-ylidene]benzamide (2g)
2,4-Dichloro-N-[3-(4,6-dichlorobenzo[d]thiazol-2-yl)-4-methylthiazol-2(3H)-ylidene] benzamide (2j)
Results and discussion
The synthesis of the title compounds (2a-k) was carried out according to the synthetic route sketched in the Scheme. Thus suitably substituted anilines were converted into the requisite benzo[d]thiazol-2-amines by reaction with thiocyanogen generated in situ from bromine and potassium thiocyanate in acidic medium. 
Conclusion
Synthesis of a number of iminothiazol-benzothiazole hybrid molecules has been carried out; they can potentially be used as new lead compounds in drug discovery.
